AGO2 |
Q9UKV8
|
argonaute RISC catalytic component 2
|
|
1.00 |
0.501 |
0.885 |
CAMP |
P49913
|
cathelicidin antimicrobial peptide
|
|
4.4E-03 |
0.466 |
0.846 |
CARD8 |
Q9Y2G2
|
caspase recruitment domain family member 8
|
|
1.8E-06 |
0.590 |
0.731 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CCL4 |
P13236 Q8NHW4
|
C-C motif chemokine ligand 4
|
Signaling
|
0.24 |
0.466 |
0.923 |
CCL4L1 |
P13236 Q8NHW4
|
C-C motif chemokine ligand 4 like 1
|
|
0.34 |
0.534 |
0.885 |
CCL4L2 |
P13236 Q8NHW4
|
C-C motif chemokine ligand 4 like 2
|
|
8.9E-02 |
0.535 |
0.885 |
CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
CCN6 |
O95389
|
cellular communication network factor 6
|
Signaling
|
6.2E-04 |
0.568 |
0.731 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CD27 |
P26842
|
CD27 molecule
|
|
1.0E-02 |
0.517 |
0.692 |
CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
CFP |
P27918
|
complement factor properdin
|
|
0.69 |
0.573 |
0.692 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |
ESAT |
|
esterase activator
|
|
|
0.716 |
0.308 |
FOXO3 |
O43524
|
forkhead box O3
|
|
0.99 |
0.431 |
0.808 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
GZMB |
P10144
|
granzyme B
|
Enzyme
|
3.7E-14 |
0.453 |
0.808 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |